Trends in Digital Patient Engagement 2017

Publication Date:           June 2017
Number of Pages:          75
Number of figures:         38
Report Price:                 $2,495 U.S. Dollars
 
enterprise pricing available upon request

Recent news coverage
Customer testimonials

Introduction (download paper overview)

Trends in Digital Patient Engagement presents the findings of an end-
user market study focused on the digital engagement tool usage and
adoption by hospital-based patients and clinical staff across the United
States.  

Content for Trends in Digital Patient Engagement was derived from more
than 100 in-depth interviews with healthcare professionals working in
hospital-based environments who are technically competent and
representative of a broad range of medical specialties, organization types,
and organization sizes.

The telephone interviews were conducted over a three-month period
starting in January 2017.  During the interviews, Spyglass identified:
  • clinical process gaps for engaging patients and family members
    within the care process,
  • current digital engagement tool usage models,
  • barriers for widespread digital engagement tool adoption during
    hospitalization, and
  • challenges for integrating digital engagement tools with existing
    evidence-based pathways and care management programs.

Spyglass also evaluated key vendor product offerings and identified early
adopter organizations that have successfully deployed these solutions.


Target Audience

  • Software and hardware vendors, systems integrators and
    management consulting groups who are selling hardware,
    applications and services into the healthcare industry
  • Healthcare administrators and IT executives who are making
    strategic decision to fund clinical information technology solutions
  • Clinicians who are involved in informatics and clinical system
    evaluation and selection
  • Investment bankers and private equity investors


Abstract

Digital patient engagement tools are poised to transform the way
patients and family members are engaged, educated, and empowered to
take a more active role in managing their health across the care continuum
within hospitals, ambulatory environments, clinics, physician offices, and
even at home.  

According to the Robert Wood Johnson Foundation, a growing body of
evidence suggests that patients who are more engaged in their health care
have better health outcomes, experience fewer complications, and lower
costs compared to patients who are less involved.  

Hospital investments in digital engagement tools are being driven by
several provisions with the Affordable Care Act including the Meaningful
Use Program, various value-based care programs, Hospital Readmission
Reduction Program, and HCAHPS Patient Satisfaction Survey.

With the transition toward patient and family centered care models and the
adoption of various at-risk reimbursement models, hospitals surveyed are
evaluating next generation digital engagement tools to help achieve the
Triple AIM by helping reduce health care costs, improve care quality and
outcomes, and increase patient and provider satisfaction.  

Hospitals are making significant digital engagement tools
investments.
 Eighty-nine percent of hospitals surveyed have invested
and 90 percent are planning incremental investments in digital
engagement tools including EHR-based patient portals and TV-based
interactive patient systems.  

Hospitals are targeting chronically ill patients.  Eighty-nine percent of
hospitals surveyed report that future investments focus on integrating
digital engagement tools with evidence-based pathways and care
management programs to support chronically ill patients with CHF, COPD,
diabetes, asthma, cancer and stroke.  

Hospitals are exploring collaboration opportunities with payers.  
Forty-nine percent of hospitals surveyed were exploring collaboration
opportunities with CMS and other 3rd party payers to subsidize patient
engagement initiatives associated with value-based care programs.  

Hospitals are facing challenges to support widespread
deployments
including low end-user adoption, poorly defined
requirements, and lack of evidence demonstrating clinical efficacy.  
Spyglass Consulting Group
Market Intelligence for Competitive Advantage